Santen Pharmaceutical Co., Ltd.

Teyenkang's wholly owned subsidiary Shandong Huabo Kaisheng Biotechnology Co., Ltd. has received the Drug Registration Certificate for Diquafosol Sodium Eye Drops issued by the National Medical Products Administration. The eye drops are indicated for dry eye patients diagnosed with keratoconjunctival epithelial damage accompanied by tear abnormalities. The original drug was developed by Santen Pharmaceutical Co., Ltd. According to data from the Moxiang Pharmaceutical Drug Sales Database, total terminal sales of Diquafosol Sodium Eye Drops in 2023 amounted to 228 million yuan. In the first half of 2026, Teyenkang achieved revenue of 320 million yuan and net profit attributable to the parent company of 3.72 million yuan.

SpyGlass Pharma, Inc. announced today it has acquired all outstanding shares of common stock of Advanced Vision Science, Inc., an ophthalmic medical device company and manufacturer of intraocular lenses and lens materials, for approximately $13 million in cash. AVS was a wholly owned subsidiary of Santen Pharmaceutical Co., Ltd. and is the current supplier of the intraocular lens used in SpyGlass Pharma's two Phase 3 registrational trials evaluating the BIM-IOL System. The acquisition secures scalable commercial intraocular lens manufacturing capacity for SpyGlass Pharma's lead product candidate and accelerates its pathway to adding premium lens options into its intraocular-lens-based drug delivery system. Under the agreement, AVS will be the exclusive manufacturer and supplier of several types of intraocular lenses to Santen for commercialization in Japan, and will continue to license its glistening-free hydrophobic acrylic lens material to Bausch + Lomb for use in the enVista intraocular lens line and manufacture products for other global intraocular lens companies. SpyGlass Pharma said it intends to continue supporting AVS customers and licensees utilizing their proprietary intraocular lens material technology, such as Santen, Bausch + Lomb, and other global intraocular lens companies.